Figure 1
From: Tolerance and rebound with zafirlukast in patients with persistent asthma

Study Design. BDR bronchodilator reversibility, PbE peripheral blood eosinophils, SpE sputum eosinophils, eNO exhaled nitric oxide levels.
From: Tolerance and rebound with zafirlukast in patients with persistent asthma
Study Design. BDR bronchodilator reversibility, PbE peripheral blood eosinophils, SpE sputum eosinophils, eNO exhaled nitric oxide levels.